Phase II study of concomitant chemoradiotherapy with local hyperthermia and metronidazole for locally advanced fixed rectal cancer
/in Colorectal Cancer, Hyperthermia, International Publications /von 2013-09-01 / Colorectal Dis 2013 Sep;15(9):1107-14Heat-shock proteins as dendritic cell-targeting vaccines–getting warmer
/in Dendritic Cells, Hyperthermia, International Publications /von 2013-08-01 / Immunology 2013 Aug;139(4):407-15Re-irradiation and hyperthermia after surgery for recurrent breast cancer
/in Breast Cancer, Hyperthermia, International Publications /von 2013-06-03 / Radiother Oncol 2013 Nov;109(2):188-93Identification of common gene networks responsive to mild hyperthermia in human cancer cells
/in Hyperthermia, International Publications /von 2013-04-30 / Int. J. Mol. Med. 2013 Jul;32(1):195-202Hyperthermia versus Oncothermia: Cellular Effects in Complementary Cancer Therapy
/in Hyperthermia, International Publications /von 2013-04-14 / Evid Based Complement Alternat Med 2013;2013:672873Oncothermia: a new paradigm and promising method in cancer therapies
/in Hyperthermia, International Publications /von 2013-01-01 / Acupunct Electrother Res 2013;38(3-4):161-97A seven-year disease-free survivor of malignant pleural mesothelioma treated with hyperthermia and chemotherapy: a case report
/in Hyperthermia, International Publications, Malignant Pleural Mesothelioma /von 2012-12-28 / J Med Case Rep 2012 Dec;6:427Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2012-12-17 / Int J Hyperthermia 2013;29(1):8-16Short-term hyperthermia promotes the sensitivity of MCF-7 human breast cancer cells to paclitaxel
/in Breast Cancer, Hyperthermia, International Publications /von 2012-12-11 / Biol. Pharm. Bull. 2013;36(3):376-83IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de